抗独特型抗体可以解释在草花粉免疫治疗后变应原-IgE与B细胞结合受到抑制的现象。 - Suppr | 超能文献

Anti-idiotype antibodies could explain inhibition of allergen-IgE binding to B cells after grass pollen immunotherapy.

作者信息

Simon Michael R

出版信息

J Allergy Clin Immunol. 2004 Jun;113(6):1225; author reply 1225-6. doi: 10.1016/j.jaci.2004.01.776.

DOI:10.1016/j.jaci.2004.01.776

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Anti-idiotype antibodies could explain inhibition of allergen-IgE binding to B cells after grass pollen immunotherapy.抗独特型抗体可以解释在草花粉免疫治疗后变应原-IgE与B细胞结合受到抑制的现象。

J Allergy Clin Immunol. 2004 Jun;113(6):1225; author reply 1225-6. doi: 10.1016/j.jaci.2004.01.776.

2

Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.草花粉免疫治疗后IgG抗体对变应原-IgE与B细胞结合的抑制作用。

J Allergy Clin Immunol. 2003 Nov;112(5):915-22. doi: 10.1016/s0091-6749(03)02022-0.

3

Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.注射草花粉免疫治疗期间和停止治疗 5 年后基于重组变应原的抗体应答监测。

Allergy. 2011 Sep;66(9):1174-82. doi: 10.1111/j.1398-9995.2011.02592.x. Epub 2011 Apr 11.

4

Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.在对 Timothy 草花粉提取物进行皮下免疫治疗的剂量递增过程中，预处理 IgE 致敏模式决定 IgG4 反应的分子特征。

J Allergy Clin Immunol. 2016 Feb;137(2):562-70. doi: 10.1016/j.jaci.2015.05.023. Epub 2015 Jun 30.

5

Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.来自鸭茅的重组花粉过敏原：草花粉免疫治疗后，人类IgE在鸭茅Dac g II与黑麦草Lol p I/II之间交叉反应性增加的初步证据。

Immunology. 1992 Jul;76(3):389-96.

6

Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.短期舌下免疫治疗过程中针对草花粉过敏原的免疫球蛋白E和G抗体谱

J Investig Allergol Clin Immunol. 2007;17(3):131-6.

7

Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.对过敏性患者用梯牧草花粉提取物进行皮下免疫治疗诱导产生的重组和天然梯牧草花粉（rPhl p 1、2、5、6、7、11、12和nPhl p 4）特异性IgG4抗体的评估。

Int Arch Allergy Immunol. 2004 Sep;135(1):44-53. doi: 10.1159/000080042. Epub 2004 Jul 30.

8

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.对新的B细胞表位产生抗体反应表明了变应原免疫疗法的疫苗接种特性。

Eur J Immunol. 1999 Jun;29(6):2026-36. doi: 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2.

9

One grass or many? Does allergy distinguish among species?一种草还是多种草？过敏反应能区分不同物种吗？

Drugs Today (Barc). 2008 Dec;44 Suppl B:65-7.

10

The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.草花粉变应原免疫疗法对变应性鼻炎儿童临床和免疫学参数的影响。

Pediatr Allergy Immunol. 2006 Sep;17(6):396-407. doi: 10.1111/j.1399-3038.2006.00442.x.

引用本文的文献

1

[From the allergen-recognition by antibodies to new therapeutic concepts].[从抗体对过敏原的识别到新的治疗概念]

Wien Med Wochenschr. 2008;158(1-2):13-8. doi: 10.1007/s10354-007-0496-5.

2

The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.IgE 介导的过敏原结合（FAB）检测法：一种基于流式细胞术的新型检测抑制性抗体反应方法的验证

J Immunol Methods. 2006 Dec 20;317(1-2):71-9. doi: 10.1016/j.jim.2006.09.004. Epub 2006 Oct 5.